{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:40:12Z","timestamp":1770910812047,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/maj.0b013e31827871dc","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T12:18:28Z","timestamp":1357820308000},"page":"221-225","source":"Crossref","is-referenced-by-count":36,"title":["Pulmonary Hypertension Idiopathic Pulmonary Fibrosis: A Dastardly Duo"],"prefix":"10.1016","volume":"346","author":[{"given":"J.","family":"Shaun Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gorbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianne","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curt J.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31827871dc_bb0005","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0020","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1378\/chest.128.4.2393","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"128","author":"Nadrous","year":"2005","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1164\/rccm.200608-1153CC","article-title":"Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots","volume":"175","author":"Nathan","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000114246","article-title":"Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"76","author":"Nathan","year":"2008","journal-title":"Respiration"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0035","first-page":"A369","article-title":"Pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis when listed for lung transplantation (LT) and at LT","volume":"3","author":"Yang","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0040","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4065\/84.2.191","article-title":"Pulmonary hypertension: diagnosis and management","volume":"84","author":"McGoon","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1378\/chest.06-3087","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"132","author":"Patel","year":"2007","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200308-1142OC","article-title":"Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension","volume":"170","author":"Leuchte","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1378\/chest.06-2485","article-title":"Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis","volume":"131","author":"Nathan","year":"2007","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.07-2488","article-title":"Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"133","author":"Zisman","year":"2008","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0075","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.rmed.2007.05.012","article-title":"Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"101","author":"Zisman","year":"2007","journal-title":"Respir Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0025-6196(11)61030-6","article-title":"Pulmonary hypertension in patients with interstitial lung diseases","volume":"82","author":"Ryu","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0085","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0090","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1378\/chest.118.4.1077","article-title":"Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension","volume":"118","author":"Strange","year":"2000","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0095","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.vph.2006.01.013","article-title":"A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease","volume":"44","author":"Madden","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.vph.2007.06.003","article-title":"Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?","volume":"47","author":"Madden","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vph.2009.04.002","article-title":"Sildenafil therapy in secondary pulmonary hypertension: is there benefit in prolonged use?","volume":"51","author":"Chapman","year":"2009","journal-title":"Vascul Pharmacol"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1378\/chest.06-2101","article-title":"Sildenafil improves walk distance in idiopathic pulmonary fibrosis","volume":"131","author":"Collard","year":"2007","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial","volume":"360","author":"Ghofrani","year":"2002","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00408-009-9209-8","article-title":"Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis","volume":"188","author":"Jackson","year":"2010","journal-title":"Lung"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"10.1097\/MAJ.0b013e31827871dc_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2362.2006.01688.x","article-title":"Survival in patients with pulmonary arterial hypertension treated with first-line bosentan","volume":"36","author":"McLaughlin","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0145","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","article-title":"Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension","volume":"120","author":"Rubens","year":"2001","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1165\/ajrcmb.16.2.9032126","article-title":"Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines","volume":"16","author":"Saleh","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"184","author":"King","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0165","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.160.2.9810008","article-title":"Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis","volume":"160","author":"Olschewski","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0175","first-page":"335","article-title":"The American Society for Transplant Physicians (ASTP)\/American Thoracic Society(ATS)\/European Respiratory Society (ERS)\/International Society for Heart and Lung Transplantation(ISHLT)","volume":"158","author":"International guidelines for the selection of lung transplant candidates","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31827871dc_bb0180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.healun.2004.08.009","article-title":"Impact of secondary pulmonary hypertension on lung transplant outcome","volume":"24","author":"Fitton","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915305450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915305450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T01:01:03Z","timestamp":1562547663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915305450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0002962915305450"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31827871dc","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}